Skip to main content
OpenTrials

Clinical trial condition

Neoplastic Processes

Explore clinical trials studying Neoplastic Processes. Study availability and eligibility vary by location and protocol.

3,266 public trials 688 recruiting studies
Refine in advanced search Browse all conditions

Neoplastic Processes trial results

Active, Not Recruiting

Safety and Preliminary Anti-Tumor Activity of TYRA-300 in Advanced Urothelial Carcinoma and Other Solid Tumors With FGFR3 Gene Alterations

NCT05544552

Conditions
Advanced Solid Tumor, Advanced Urothelial Carcinoma, Bladder Cancer, +31 more
Locations
  • Dana Farber Cancer Institute Boston, Massachusetts, United States
  • UMass Memorial Medical Center Worchester, Massachusetts, United States
  • Memorial Sloan Kettering Cancer Center (MSKCC) New York, United States
  • Duke Cancer Institute (DCI) - Duke Cancer Center Durham, North Carolina, United States
View all 19 locations
View Trial Details
Active, Not Recruiting

Stereotactic Radiotherapy for Oligo-Progressive Metastatic Cancer (The STOP Trial)

NCT02756793

Conditions
Metastatic Cancer, Neoplasm Metastasis, Neoplasms, +3 more
Locations
  • Alberta Health Services-Cross Cancer Institute Edmonton, Alberta, Canada
  • BC Cancer - Prince George Prince George, British Columbia, Canada
  • BC Cancer Fraser Valley Centre Surrey, British Columbia, Canada
  • BC Cancer Agency Branch Vancouver, British Columbia, Canada
View Trial Details
Active, Not Recruiting

A Study of MK-6837 as a Monotherapy and Combination Therapy in Participants With Advanced/Metastatic Solid Tumors (MK-6837-001)

NCT06460961

Conditions
Neoplasm Metastasis, Neoplasms, Neoplastic Processes, +3 more
Locations
  • Atlantic Health System Morristown Medical Center ( Site 4001) Morristown, New Jersey, United States
  • Providence Portland Medical Center ( Site 4002) Portland, Oregon, United States
  • South Texas Accelerated Research Therapeutics (START) ( Site 4003) San Antonio, Texas, United States
  • Westmead Hospital ( Site 1002) Westmead, New South Wales, Australia
View Trial Details
Active, Not Recruiting

A Safety Extension Study of Trastuzumab Emtansine in Participants Previously Treated With Trastuzumab Emtansine Alone or in Combination With Other Anti-Cancer Therapy in One of the Parent Studies

NCT00781612

Conditions
Neoplasm Metastasis, Neoplasms, Neoplastic Processes, +2 more
Locations
  • City of Hope National Medical Center Duarte, California, United States
  • Can Care Assoc Med Group Inc Redondo Beach, California, United States
  • Univ of Calif, San Francisco San Francisco, California, United States
  • Central Coast Medical Oncology San Luis Obispo, California, United States
View all 178 locations
View Trial Details

Related conditions